Answers are grounded in this paper and cite their sources.
In vitro and in vivo experiments demonstrate enhanced antitumor effects in triple-negative breast cancer using a novel liposomal formulation.
In vitro and in vivo experiments demonstrated that DOX-(PPD)-LIP@M improves formulation stability and enhances the antitumor effect of DOX.
No takes yet. Share an insight, caveat, or question.
Bai et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: